This company listing is no longer active
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
Acerus Pharmaceuticals バランスシートの健全性
財務の健全性 基準チェック /06
主要情報
-329.8%
負債資本比率
US$45.82m
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | US$3.02m |
| エクイティ | -US$13.89m |
| 負債合計 | US$61.57m |
| 総資産 | US$47.67m |
財務の健全性に関する最新情報
Recent updates
Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)
Mar 14
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?
Mar 12Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares
Jan 22The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares
Nov 30
財務状況分析
短期負債: ASP has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
長期負債: ASP has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
デット・ツー・エクイティの歴史と分析
負債レベル: ASP has negative shareholder equity, which is a more serious situation than a high debt level.
負債の削減: ASP's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
貸借対照表
キャッシュ・ランウェイ分析
過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。
安定したキャッシュランウェイ: ASP has less than a year of cash runway based on its current free cash flow.
キャッシュランウェイの予測: ASP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 45.6% each year